Success Metrics

Clinical Success Rate
100.0%

Based on 10 completed trials

Completion Rate
100%(10/10)
Active Trials
1(8%)
Results Posted
40%(4 trials)

Phase Distribution

Ph phase_1
1
8%
Ph phase_2
4
31%
Ph phase_3
1
8%
Ph phase_4
1
8%
Ph not_applicable
2
15%

Phase Distribution

1

Early Stage

4

Mid Stage

2

Late Stage

Phase Distribution9 total trials
Phase 1Safety & dosage
1(11.1%)
Phase 2Efficacy & side effects
4(44.4%)
Phase 3Large-scale testing
1(11.1%)
Phase 4Post-market surveillance
1(11.1%)
N/ANon-phased studies
2(22.2%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

90.9%

10 of 11 finished

Non-Completion Rate

9.1%

1 ended early

Currently Active

1

trials recruiting

Total Trials

13

all time

Status Distribution
Active(1)
Completed(10)
Terminated(1)
Other(1)

Detailed Status

Completed10
Active, not recruiting1
unknown1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
13
Active
1
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (11.1%)
Phase 24 (44.4%)
Phase 31 (11.1%)
Phase 41 (11.1%)
N/A2 (22.2%)

Trials by Status

completed1077%
active_not_recruiting18%
unknown18%
withdrawn18%

Recent Activity

1 active trials
Showing 5 of 13
active_not_recruitingphase_2

A Study of Teropavimab and Zinlirvimab in Combination With Capsid Inhibitor Lenacapavir in Virologically Suppressed Adults With HIV-1 Infection

NCT05729568
completedphase_2

Proof of Concept Treatment Study of Orally Administered VH4004280 or VH4011499 in HIV-1 Infected Adults

NCT06039579
completedphase_2

VH4524184 Proof-of-Concept in Treatment-Naïve Adults Living With HIV-1

NCT06214052
completedphase_2

Study to Evaluate Safety, Tolerance and Efficacy of ASC22 Combined With ART in Subjects With HIV

NCT05330143
completedphase_1

Testing the Addition of an Experimental Medication MK-3475 (Pembrolizumab) to Usual Anti-Retroviral Medications in Patients With HIV and Cancer

NCT02595866
View all 13 trials

Clinical Trials (13)

Showing 13 of 13 trials
NCT05729568Phase 2

A Study of Teropavimab and Zinlirvimab in Combination With Capsid Inhibitor Lenacapavir in Virologically Suppressed Adults With HIV-1 Infection

Active Not Recruiting
NCT06039579Phase 2

Proof of Concept Treatment Study of Orally Administered VH4004280 or VH4011499 in HIV-1 Infected Adults

Completed
NCT06214052Phase 2

VH4524184 Proof-of-Concept in Treatment-Naïve Adults Living With HIV-1

Completed
NCT05330143Phase 2

Study to Evaluate Safety, Tolerance and Efficacy of ASC22 Combined With ART in Subjects With HIV

Completed
NCT02595866Phase 1

Testing the Addition of an Experimental Medication MK-3475 (Pembrolizumab) to Usual Anti-Retroviral Medications in Patients With HIV and Cancer

Completed
NCT04147325

A Study to Evaluate Virologic Response in Participants Newly Diagnosed With HIV-1

Completed
NCT04297501

Gut Microbiota Changes of HIV Patients Before and After One Year of ART

Completed
NCT02624453Not Applicable

Pre-Antiretroviral Therapy (ART) Cryptococcal Antigen Screening in AIDS

Unknown
NCT00461266Phase 4

ESP Study: A Study to Assess the Effect of Adding Fuzeon (Enfuvirtide) to an Antiretroviral Regimen in Fuzeon-Naive Patients With Sustained HIV Viral Suppression.

Withdrawn
NCT01461876

Obesity in HIV After Antiretroviral Therapy

Completed
NCT00144365Phase 3

Comparison of Facility and Home-based ART Delivery Systems in Uganda

Completed
NCT00219934

Observational Study of Treated and Untreated Acute and Early HIV-1 Infection

Completed
NCT00004739Not Applicable

The Metabolic Effects of Protease Inhibitors in HIV Infected Children

Completed

All 13 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
13